Hematology

ADCETRIS (brentuximab vedotin) receives approval in Japan for frontline Hodgkin lymphoma treatment

Precision’s Epiontis ID diagnostic detects many rare, severe immune diseases in newborns

A collection of news of recently published papers

Duo will offer advanced preclinical oncology services

Researchers identify a histone that could have significance in treating aggressive breast cancer

MIT study reveals atomic structure of tropoelastin, showing what goes wrong in some diseases

Mustang Bio and St. Jude enter license agreement

Companies combine proprietary tech to create bispecific therapies against novel tumor targets

A roundup of clinical trial startups and initial breakthroughs

Mount Sinai combines DNA and RNA sequencing to pinpoint treatment options for multiple myeloma patients

Avelumab plus axitinib significantly improved progression-free survival in previously untreated patients with advanced renal cell carcinoma in Phase III study

Data demonstrate statistically significant dose-dependent effects on SYNB1618 activity-associated biomarkers, supporting further development; SYNB1618 dose established for treatment arm of ongoing Phase 1/2a study in patients with PKU